Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Studies indicate that there is a very low likelihood that people with HIV have preexisting resistance to the medication.
As long-acting injectables near approval, daily pill versions of the same drugs show long-term benefit.
Cabotegravir plus rilpivirine maintenance therapy worked equally well when taken monthly or every two months.
Researchers followed a small group of people with highly drug-resistant virus taking injectable antibody.
Here are the HIV treatment news stories with the most views this year.
The actor is still in the FDA trial of an injectable HIV med.
The actor is part of an FDA study on the weekly injectable PRO 140.
Treating HIV without the need for daily meds may become a reality by the decade’s end.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.